The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Studies on the induction of anterior chamber‐associated immune deviation (ACAID) III. Induction of ACAID depends upon intraocular transforming growth factor‐β
Abstract
Delayed hypersensitivity (DH), the prototypical form of cell‐mediated immune responsiveness, is mediated with the participation of considerable nonspecific inflammation which necessarily disrupts the anatomic integrity of involved and adjacent tissues. Damage of this type is of minor consequence to many visceral and cutaneous organs, but is of devastating consequence for organs such as the eye and the brain. At least in the case of the eye, the organ is remarkably adept at regulating the immune system's ability to respond to intraocular antigens by selectively down‐regulating both the induction and expression of delayed hypersensitivity while leaving other effector modalities intact. This ability of the eye to selectivity down‐regulate systemic DH responses to intracamerally inoculated antigens is known as anterior chamber‐associated immune deviation (ACAID) and is mediated in part by antigen‐specific regulatory T cells. Recent work suggests that macrophages (MΦ) that reside in the iris and ciliary body can migrate out of an antigen‐bearing eye and activate regulatory T cells within the spleen. In an effort to understand the mechanism by which intraocular MΦ interact with antigen in the anterior chamber of the eye (AC) and subsequently induce splenic regulatory cells in ACAID, we have investigated what role, if any, the AC microenvironment itself plays in ACAID induction. The results reveal that CD45− parenchymal iris/ciliary cells secrete a soluble factor(s) locally and into the aqueous humor which endows resident, mature MΦ with ACAID‐inducing capabilities. Mice receiving infusions of these altered, antigen‐pulsed MΦ are incapable of mounting a significant DH response following immunization with antigen in adjuvant. Importantly, the ACAID‐inducing effect is achieved when conventional, extraocular MΦ are exposed in vitro to a soluble factor present in aqueous humor or culture SN from iris and ciliary body cells. Further investigations into the identity of this factor reveal it to be transforming growth factor‐β (TGF‐β). The role of TGF‐β in the generation of ACAID, as well as the implications of these findings to an understanding of immunologic privilege in general, are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Demidem, A., Taylor, J. R., Grammer, S. F., & Streilein, J. W. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12469761 · Cited by 50
Self-citation
Cited by
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807
Self-citationInflammation in Glaucoma: From the back to the front of the eye, and beyond
Baudouin, C., Kolko, M., Melik-Parsadaniantz, S., & Messmer, E. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100916 · Cited by 454
Lin, H.-H., Faunce, D. E., Stacey, M., Terajewicz, A., Nakamura, T., Zhang-Hoover, J., Kerley, M., Mucenski, M. L., Gordon, S., & Stein-Streilein, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042307 · Cited by 385
CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance
Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R., & Ferguson, T. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80305-2 · Cited by 382
Changes in aqueous humor dynamics with age and glaucoma
Gabelt, B. T., & Kaufman, P. L. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.10.003 · Cited by 377
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation
Streilein, J. W. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102574 · Cited by 367
Self-citationSonoda, K.-H., Exley, M., Snapper, S., Balk, S. P., & Stein-Streilein, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1215 · Cited by 354
Tissue-based class control: the other side of tolerance
Matzinger, P., & Kamala, T. (2011) · Nature Reviews Immunology · doi:10.1038/nri2940 · Cited by 343
TGFβ2-Induced Changes in Human Trabecular Meshwork: Implications for Intraocular Pressure
Fleenor, D. L., Shepard, A. R., Hellberg, P. E., Jacobson, N., Pang, I.-H., & Clark, A. F. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-1060 · Cited by 322
Antitumor effect of locally produced CD95 ligand
Seino, K.-I., Kayagaki, N., Okumura, K., & Yagita, H. (1997) · Nature Medicine · doi:10.1038/nm0297-165 · Cited by 312
The Neuropathological and Behavioral Consequences of Intraspinal Microglial/Macrophage Activation
Popovich, P. G., Guan, Z., McGaughy, V., Fisher, L., Hickey, W. F., & Basso, D. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.7.623 · Cited by 295
The role of FasL-induced apoptosis in immune privilege
Griffith, T. S., & Ferguson, T. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)81663-5 · Cited by 253
Bucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD
Algvere, P. V., Gouras, P., & Dafgård Kopp, E. (1999) · European Journal of Ophthalmology · doi:10.1177/112067219900900310 · Cited by 219
STEIN-STREILEIN, J., & STREILEIN, J. W. (2002) · International Reviews of Immunology · doi:10.1080/08830180212066 · Cited by 218
Self-citationB7-H1-Induced Apoptosis as a Mechanism of Immune Privilege of Corneal Allografts
Hori, J., Wang, M., Miyashita, M., Tanemoto, K., Takahashi, H., Takemori, T., Okumura, K., Yagita, H., & Azuma, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.5928 · Cited by 208
Immunoregulatory mechanisms of the eye
Streilein, J. W., Wilbanks, G. A., & Cousins, S. W. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90253-h · Cited by 157
Self-citationTakeuchi, M., Kosiewicz, M. M., Alard, P., & Streilein, J. W. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270709 · Cited by 119
Self-citationReview of Ocular Immune Privilege in the Year 2010: Modifying the Immune Privilege of the Eye
Hori, J., Vega, J. L., & Masli, S. (2010) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2010.512696 · Cited by 64
Ocular Inflammation and Treatment Emergent Adverse Events in Retinal Gene Therapy
Mehta, N., Robbins, D. A., & Yiu, G. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000366 · Cited by 33
Metadata
- Authors
- Wilbanks, G. A., Mammolenti, M., & Streilein, J. W.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1992-01
- Volume
- 22
- Issue
- 1
- Pages
- 165-173
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2165894588
- Cited by
- 249
- References
- 1
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.